CT-027: Multidimensional Geriatric Assessment for Elderly Hematological Patients (≥60 years) Submitted to Allogeneic Stem Cell Transplantation; A French-Italian 10-year Experience on 228 Patients

Context Evaluation of elderly patients\u0027 eligibility for allogeneic stem cell transplantation (allo-SCT) is crucial. A comprehensive geriatric assessment (CGA) has demonstrated important prognostic value in hematology. However, its role in allo-SCT transplant setting has still to be defined. Objective To evaluate the feasibility and efficacy of the Fondazione Italiana Linfomi (FIL)-score, a combined comorbidity (CIRS-G) and functionality (ADL/IADL) score, on allo-SCT outcome. Patients and methods This is a retrospective study involving 228 elderly (\u003e60y) patients consecutively submitted to allo-SCT at our centers from 2008 to 2018. Median follow-up 36 months (range, 1-118). Results The median age was 64 years (range, 60-76), and 155 (68%) were male. AML was the most common indication for transplant (53%), DRI was high/very-high in 42% of cases. A matched unrelated, sibling or alternative donor was utilized in 41%, 30%, and 29% of cases, respectively. Stem cell source was derived from peripheral blood in 82% of patients. Myeloablative conditioning regimen was reserved for only 20% of patients. Based on FIL score, available in 215 patients, 125 (58%) patients were classified as “fit” and 90 as “unfit/frail.” According to FIL score, fit patients were more frequently diagnosed with AML (p Conclusions A comprehensive geriatric assessment with FIL score seems to add significant prognostic information in elderly patients submitted to allo-SCT. The pre-transplant adoption of this easy-to-use tool could help the patients\u0027 selection and management.